Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Virus hepatitis update.

J A Summerfield1

  • 1Division of Medicine, Imperial College School of Medicine, St Mary's Hospital, London.

Journal of the Royal College of Physicians of London
|September 27, 2000
PubMed
Summary
This summary is machine-generated.

Hepatitis B and C are significant global health issues, leading to chronic liver disease, cirrhosis, and cancer. While vaccines exist for Hepatitis A and B, new treatments offer improved outcomes for chronic Hepatitis C, with ongoing research for more effective therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical potential of mannose-binding lectin-replacement therapy.

Biochemical Society transactions·2003
Same author

Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin alpha genes.

Clinical and experimental immunology·2001
Same author

Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group.

Lancet (London, England)·1999
Same author

Mannose-binding protein in HIV-seropositive patients does not contribute to disease progression or bacterial infections.

International journal of STD & AIDS·1998
Same author

Fractured rib, pleural effusion and ascites.

Lancet (London, England)·1998
Same author

Pancreatic abnormalities and AIDS related sclerosing cholangitis.

Genitourinary medicine·1997
Same journal

A Change of Government and Its Effect on the NHS Hospital Outpatient Service.

Journal of the Royal College of Physicians of London·2019
Same journal

Erratum: Model for the Organisation of a Community-Based Rehabilitation Service.

Journal of the Royal College of Physicians of London·2019
Same journal

Telemedicine and beyond.

Journal of the Royal College of Physicians of London·2019
Same journal

Palliative Care in General Medicine.

Journal of the Royal College of Physicians of London·2019
Same journal

Medical Negligence.

Journal of the Royal College of Physicians of London·2019
Same journal

In Response.

Journal of the Royal College of Physicians of London·2019
See all related articles

Area of Science:

  • Hepatology
  • Virology
  • Public Health

Background:

  • Seven hepatitis viruses (A, B, C, D, E, G, TTV) are recognized, with Hepatitis B and C posing major global health challenges.
  • Hepatitis B and C infections can lead to severe liver conditions including chronic hepatitis, cirrhosis, and primary liver cancer.
  • Chronic Hepatitis C is a significant concern in Western Europe, contributing substantially to cirrhosis and liver transplants.

Purpose of the Study:

  • To review the current landscape of hepatitis viruses, focusing on the public health impact of Hepatitis B and C.
  • To discuss existing and emerging treatment strategies for chronic Hepatitis B and C.
  • To highlight the ongoing research efforts for novel antiviral therapies against Hepatitis C.

Main Methods:

  • Literature review of hepatitis virus classifications and their associated diseases.

Related Experiment Videos

  • Analysis of current treatment modalities for Hepatitis B and C, including vaccines and antiviral agents.
  • Overview of therapeutic advancements and future research directions for Hepatitis C.

    • Main Results:

    • Hepatitis A and E typically cause self-limiting illness, though fulminant hepatic failure can occur.
    • Hepatitis B and C are responsible for significant long-term liver damage and cancer.
    • Current treatments like interferon alpha show limited efficacy, but combination therapy and new drugs like lamivudine offer improved prospects.

    Conclusions:

    • Hepatitis B and C represent critical public health concerns requiring effective management and prevention strategies.
    • Advancements in antiviral therapies, including combination treatments and reverse transcriptase inhibitors, are improving patient outcomes.
    • Continued research into new antiviral agents is essential for developing more effective treatments for chronic Hepatitis C.